Moderator of

• 25525

  +

  Guiding the best targeted treatment (ID 27)

  • Event: ELCC 2018
  • Type: Multidisciplinary Tumour Board
  • Track:
  • Presentations: 3
  • Now Available
  • Moderators:E. Smit, F. Lopez-Rios
  • Coordinates: 4/13/2018, 14:45 - 16:15, Room A

  • 25526

    +

    Can we rely on liquid biopsy for treatment decision at the time of acquired resistance? (Now Available) (ID 109)

    14:45 - 15:15  |  Presenting Author(s): J. Remon-Masip
    • Abstract
    • Presentation
    • Slides

    Abstract not provided

    Only Members that have purchased this event or have registered via an access code will be able to view this content. To view this presentation, please login, select "Add to Cart" and proceed to checkout. If you would like to become a member of IASLC, please click here.

    Only Active Members that have purchased this event or have registered via an access code will be able to view this content. To view this presentation, please login or select "Add to Cart" and proceed to checkout.

  • 25527

    +

    EGFR activating mutation plus exon 20 co-mutation at baseline: Which TKI should we select for frontline treatment? (Now Available) (ID 110)

    15:15 - 15:45  |  Presenting Author(s): E. Smit
    • Abstract
    • Presentation
    • Slides

    Abstract not provided

    Only Members that have purchased this event or have registered via an access code will be able to view this content. To view this presentation, please login, select "Add to Cart" and proceed to checkout. If you would like to become a member of IASLC, please click here.

    Only Active Members that have purchased this event or have registered via an access code will be able to view this content. To view this presentation, please login or select "Add to Cart" and proceed to checkout.

  • 25528

    +

    Progression on osimertinib: When is it possible to continue with a targeted therapy? (Now Available) (ID 111)

    15:45 - 16:15  |  Presenting Author(s): D. Planchard
    • Abstract
    • Presentation
    • Slides

    Abstract not provided

    Only Members that have purchased this event or have registered via an access code will be able to view this content. To view this presentation, please login, select "Add to Cart" and proceed to checkout. If you would like to become a member of IASLC, please click here.

    Only Active Members that have purchased this event or have registered via an access code will be able to view this content. To view this presentation, please login or select "Add to Cart" and proceed to checkout.

Author of

• 25457

  +

  How can we optimise our organisation to deliver precision oncology? (ID 18)

  • Event: ELCC 2018
  • Type: Educational session
  • Track:
  • Presentations: 1
  • Moderators:P. Garrido Lopez, F. Barlesi
  • Coordinates: 4/12/2018, 16:45 - 18:15, Room A

  • 25460

    +

    The pathologist’s point of view (ID 75)

    17:25 - 17:45  |  Presenting Author(s): F. Lopez-Rios
    • Abstract
    • Slides

    Abstract not provided

    Only Active Members that have purchased this event or have registered via an access code will be able to view this content. To view this presentation, please login or select "Add to Cart" and proceed to checkout.

• 25226

  +

  State of the art of PD-L1 testing (ID 12)

  • Event: ELCC 2018
  • Type: Specialty session
  • Track:
  • Presentations: 1
  • Moderators:S. Lantuejoul, F. Hirsch
  • Coordinates: 4/12/2018, 11:00 - 12:30, Room C

  • 25229

    +

    How to improve the accuracy of PD-L1 testing (ID 50)

    11:40 - 12:00  |  Presenting Author(s): F. Lopez-Rios
    • Abstract
    • Slides

    Abstract not provided

    Only Active Members that have purchased this event or have registered via an access code will be able to view this content. To view this presentation, please login or select "Add to Cart" and proceed to checkout.